543 related articles for article (PubMed ID: 26885643)
21. [A new WHO classification of prostate tumors].
Frank GA; Andreeva YY; Moskvina LV; Efremov GD; Samoilova SI
Arkh Patol; 2016; 78(4):32-42. PubMed ID: 27600780
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.
Kouba E; Cheng L
Endocr Pathol; 2016 Sep; 27(3):188-99. PubMed ID: 27334654
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
[TBL] [Abstract][Full Text] [Related]
24. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
Fine SW
Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283
[TBL] [Abstract][Full Text] [Related]
25. [Neuroendocrine tumors of the prostate].
Bours AF; Jorion JL; Donnay M; Ledent G; Van Ruyssevelt C
Acta Urol Belg; 1993 Sep; 61(3):13-6. PubMed ID: 8256680
[TBL] [Abstract][Full Text] [Related]
26. [Neuroendocrine carcinoma of the prostate].
Bengió V; Bengió RG
Rev Fac Cien Med Univ Nac Cordoba; 2004; 61(2):74-5. PubMed ID: 16211999
[TBL] [Abstract][Full Text] [Related]
27. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
28. Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.
Heaphy CM; Haffner MC; Graham MK; Lim D; Davis C; Corey E; Epstein JI; Eisenberger MA; Wang H; De Marzo AM; Meeker AK; Lotan TL
Hum Pathol; 2020 Jul; 101():70-79. PubMed ID: 32389660
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome.
Wagner DG; Gatalica Z; Lynch HT; Kohl S; Johansson SL; Lele SM
Int J Surg Pathol; 2010 Dec; 18(6):550-3. PubMed ID: 20798067
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
Helpap B; Köllermann J; Oehler U
Urol Int; 1999; 62(3):133-8. PubMed ID: 10529661
[TBL] [Abstract][Full Text] [Related]
32. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
Romero-Rojas AE; Diaz-Perez JA; Reddy A
Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
[TBL] [Abstract][Full Text] [Related]
33. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine tumors of the lung: an update.
Rekhtman N
Arch Pathol Lab Med; 2010 Nov; 134(11):1628-38. PubMed ID: 21043816
[TBL] [Abstract][Full Text] [Related]
35. [Mixed Neuroendocrine-non-neuroendocrine Neoplasm of the Stomach that is Distributed in Depth on the Same Tumor: Inconsistent with the Definition of Mixed Adenoneuroendocrine Carcinoma in the 2010 World Health Organization Classification of Tumors of the Digestive System].
Jeong J; Jung K; Kim JH; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2019 Dec; 74(6):349-355. PubMed ID: 31870141
[TBL] [Abstract][Full Text] [Related]
36. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.
Di Sant'Agnese PA; Cockett AT
J Urol; 1994 Nov; 152(5 Pt 2):1927-31. PubMed ID: 7933249
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features.
Chang S; Choi D; Lee SJ; Lee WJ; Park MH; Kim SW; Lee DK; Jang KT
Radiographics; 2007; 27(6):1667-79. PubMed ID: 18025510
[TBL] [Abstract][Full Text] [Related]
38. Primary Prostatic Carcinoma With De Novo Diffuse Neuroendocrine Differentiation.
Galea LA; Mow C; Fine SW; Manohar P
Int J Surg Pathol; 2022 Apr; 30(2):232-236. PubMed ID: 34338584
[TBL] [Abstract][Full Text] [Related]
39. Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer.
Zamora I; Freeman MR; Encío IJ; Rotinen M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761978
[TBL] [Abstract][Full Text] [Related]
40. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Helpap B
Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
